TrialPanorama/TrialPanorama-database huggingface dataset:
Study 37462798 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 37463054 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 37463054 — Surrogate Endpoint (SUR): Complete renal response
Study 37463058 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 37464355 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 37464378 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 37464378 — Predictive Biomarker (PRD): Microsatellite instability
Study 37464378 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 37464390 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 37464448 — Predictive Biomarker (PRD): EBPL mRNA
Genes: EBPL; EBRP; ERP
Study 37464978 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 37464978 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 37464978 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 37466151 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 37466221 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37467213 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 37467318 — Predictive Biomarker (PRD): FOXO1 mRNA
Genes: FOXO1; FKHR; FOXO1A
Study 37467318 — Predictive Biomarker (PRD): GDA mRNA
Genes: GDA; KIAA1258
Study 37467452 — Predictive Biomarker (PRD): RAD51 mRNA
Genes: RAD51; RAD51A; RECA
Study 37467452 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 37467458 — Monitoring Biomarker (MOI): Cell-free DNA
Study 37467498 — Surrogate Endpoint (SUR): Blood pressure
Study 37467930 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 37468185 — Predictive Biomarker (PRD): INVS mRNA
Genes: INVS; INV; NPHP2
Study 37468836 — Predictive Biomarker (PRD): CAMLG mRNA
Genes: CAMLG; CAML; GET2
Study 37468836 — Predictive Biomarker (PRD): GALNT2 mRNA
Genes: GALNT2
Study 37468836 — Predictive Biomarker (PRD): SPINDOC mRNA
Genes: SPINDOC; C11orf84
Study 37468836 — Predictive Biomarker (PRD): THOC5 mRNA
Genes: THOC5; C22orf19; KIAA0983
Study 37468836 — Predictive Biomarker (PRD): SAMD11 mRNA
Genes: SAMD11
Study 37468890 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 37468918 — Predictive Biomarker (PRD): RCN3 mRNA
Genes: RCN3; UNQ239/PRO272
Study 37468918 — Predictive Biomarker (PRD): FSTL3 mRNA
Genes: FSTL3; FLRG; UNQ674/PRO1308
Study 37468918 — Predictive Biomarker (PRD): SCRG1 mRNA
Genes: SCRG1; UNQ390/PRO725
Study 37468918 — Predictive Biomarker (PRD): NPDC1 mRNA
Genes: NPDC1
Study 37468918 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 37468918 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 37468978 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 37468978 — Safety Biomarker (SAF): BDNF
Study 37470057 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 37470295 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 37470445 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37470772 — Surrogate Endpoint (SUR): Blood pressure
Study 37471135 — Surrogate Endpoint (SUR): Blood pressure
Study 37473964 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37474180 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study 37474184 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37474184 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 37474720 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 37474720 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 37474729 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37474729 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 37474784 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study 37474829 — Surrogate Endpoint (SUR): Blood pressure
Study 37474971 — Safety Biomarker (SAF): Bacteroidetes phylum
Study 37475004 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37475004 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37475004 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 37475004 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 37475004 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study 37475004 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 37475004 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 37475004 — Predictive Biomarker (PRD): KMT2C mRNA
Genes: KMT2C; HALR; KIAA1506; MLL3
Study 37475004 — Predictive Biomarker (PRD): Hormone receptor
Study 37475033 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37475033 — Surrogate Endpoint (SUR): Bone mineral density
Study 37475689 — Surrogate Endpoint (SUR): Blood pressure
Study 37476372 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 37476372 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37477106 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 37478283 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study 37478401 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 37478401 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 37479372 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study 37479483 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 37479812 — Surrogate Endpoint (SUR): Blood pressure
Study 37479853 — Predictive Biomarker (PRD): TPH1 mRNA
Genes: TPH1; TPH; TPRH; TRPH
Study 37479853 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study 37480005 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 37480005 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study 37480005 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 37480005 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 37480005 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 37480005 — Predictive Biomarker (PRD): CX3CR1 mRNA
Genes: CX3CR1; CMKBRL1; GPR13
Study 37480164 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 37480164 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 37480391 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 37480520 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37481477 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study 37481477 — Predictive Biomarker (PRD): MUTYH mRNA
Genes: MUTYH; MYH
Study 37481608 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 37481608 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study 37481608 — Predictive Biomarker (PRD): ENTPD1 mRNA
Genes: ENTPD1; CD39
Study 37481816 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 37482172 — Pharmacodynamic Biomarker (PDY): Fatty acid amide hydrolase 1
Genes: FAAH; FAAH1
Study 37482172 — Predictive Biomarker (PRD): CNR1 mRNA
Genes: CNR1; CNR
Study 37482217 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37482512 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 37482564 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 37482646 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 37482646 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 37482878 — Surrogate Endpoint (SUR): Probing pocket depth
Study 37483161 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 37483544 — Predictive Biomarker (PRD): CCL17 mRNA
Genes: CCL17; SCYA17; TARC
Study 37484196 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37484196 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 37484210 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 37484210 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 37485388 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 37485887 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 37486024 — Predictive Biomarker (PRD): ASPRV1 mRNA
Genes: ASPRV1; SASP
Study 37486343 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 37486343 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 37486343 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study 37486616 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 37486616 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 37486775 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37487056 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 37487056 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37487056 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37487656 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study 37488191 — Predictive Biomarker (PRD): CDK7 mRNA
Genes: CDK7; CAK; CAK1; CDKN7; MO15; STK1
Study 37488191 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37488191 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 37488191 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 37488286 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37488289 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37488448 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37488472 — Surrogate Endpoint (SUR): Blood pressure
Study 37489724 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37489819 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 37490202 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 37490268 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37490292 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 37490916 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 37490916 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 37491084 — Surrogate Endpoint (SUR): Blood pressure
Study 37491235 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 37491309 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 37491373 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study 37491482 — Monitoring Biomarker (MOI): miR-26b-5p
Genes: MIR26B
Study 37491482 — Predictive Biomarker (PRD): let-7b
Genes: MIRLET7B
Study 37491482 — Predictive Biomarker (PRD): miR-101-3p
Study 37491482 — Predictive Biomarker (PRD): miR-93
Genes: MIR93
Study 37491482 — Safety Biomarker (SAF): let-7a
Study 37491482 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-21
Genes: MIR21
Study 37491619 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study 37491889 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 37491889 — Safety Biomarker (SAF): Cyclin-dependent kinase inhibitor 1
Genes: CDKN1A
Study 37491889 — Predictive Biomarker (PRD): ERCC5 mRNA
Genes: ERCC5; ERCM2; XPG; XPGC
Study 37493020 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37493269 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37493898 — Surrogate Endpoint (SUR): Blood pressure
Study 37494942 — Monitoring Biomarker (MOI): HBV DNA
Study 37496117 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study 37496117 — Predictive Biomarker (PRD): NRP1 mRNA
Genes: NRP1; NRP; VEGF165R
Study 37496298 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 37496411 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 37496411 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 37496411 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 37496411 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study 37497337 — Predictive Biomarker (PRD): Microsatellite instability
Study 37497888 — Predictive Biomarker (PRD): TMPRSS6 mRNA
Genes: TMPRSS6; UNQ354/PRO618
Study 37498105 — Surrogate Endpoint (SUR): Blood pressure
Study 37498603 — Surrogate Endpoint (SUR): Blood pressure
Study 37498603 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 37498603 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37498650 — Surrogate Endpoint (SUR): Blood pressure
Study 37499521 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 37499521 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37499670 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 37499870 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37500072 — Predictive Biomarker (PRD): RCN1 mRNA
Genes: RCN1; RCN
Study 37500072 — Predictive Biomarker (PRD): ESD mRNA
Genes: ESD
Study 37500120 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37500339 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 37500647 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 37500950 — Surrogate Endpoint (SUR): Blood pressure
Study 37501059 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 37501059 — Predictive Biomarker (PRD): NAAA mRNA
Genes: NAAA; ASAHL; PLT
Study 37501102 — Surrogate Endpoint (SUR): Blood pressure
Study 37501102 — Surrogate Endpoint (SUR): Serum potassium
Study 37501102 — Surrogate Endpoint (SUR): Serum creatinine
Study 37502440 — Predictive Biomarker (PRD): WRAP53 mRNA
Genes: WRAP53; TCAB1; WDR79
Study 37503157 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 37503561 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 37503602 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 37503661 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 37503661 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 37504371 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37504371 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 37505117 — Predictive Biomarker (PRD): ACAD8 mRNA
Genes: ACAD8; ARC42; IBD
Study 37505393 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 37506346 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 37506513 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study 37506557 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 37507425 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 37507425 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 37507427 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37507543 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37507543 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37507543 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 37507543 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 37507657 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 37507657 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 37507692 — Surrogate Endpoint (SUR): Blood pressure
Study 37507763 — Surrogate Endpoint (SUR): Blood pressure
Study 37507802 — Predictive Biomarker (PRD): CDK7 mRNA
Genes: CDK7; CAK; CAK1; CDKN7; MO15; STK1
Study 37507802 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 37507802 — Pharmacodynamic Biomarker (PDY): Cyclin-dependent kinase 1
Genes: CDK1; CDC2; CDC28A; CDKN1; P34CDC2
Study 37507802 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 37509587 — Predictive Biomarker (PRD): GAD2 mRNA
Genes: GAD2; GAD65
Study 37515050 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37515446 — Surrogate Endpoint (SUR): Probing pocket depth
Study 37516299 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 37516818 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37516818 — Predictive Biomarker (PRD): KIR3DL1 mRNA
Genes: KIR3DL1; CD158E; NKAT3; NKB1
Study 37516841 — Predictive Biomarker (PRD): Small-inducible cytokine A11
Genes: CCL11; SCYA11
Study 37516841 — Predictive Biomarker (PRD): CD6 mRNA
Genes: CD6
Study 37516841 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study 37516867 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study 37517110 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 37517579 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study 37517799 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 37518060 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37519033 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 37519971 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 37520311 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 37520311 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 37521410 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 37521410 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37522226 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study 37522226 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 37522226 — Predictive Biomarker (PRD): CX3CR1 mRNA
Genes: CX3CR1; CMKBRL1; GPR13
Study 37523661 — Predictive Biomarker (PRD): Microsatellite instability
Study 37523939 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study 37524198 — Predictive Biomarker (PRD): BMAL1 mRNA
Genes: BMAL1; ARNTL; BHLHE5; MOP3; PASD3
Study 37524198 — Predictive Biomarker (PRD): PER1 mRNA
Genes: PER1; KIAA0482; PER; RIGUI
Study 37524198 — Predictive Biomarker (PRD): PER2 mRNA
Genes: PER2; KIAA0347
Study 37524198 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 37524201 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37524522 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 37524953 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study 37524953 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37525000 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study 37525267 — Surrogate Endpoint (SUR): Blood pressure
Study 37525354 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37525354 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 37525373 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 37525914 — Predictive Biomarker (PRD): GJA4 mRNA
Genes: GJA4
Study 37526149 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study 37526237 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 37526748 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study 37526856 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 37526856 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 37527039 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37527897 — Surrogate Endpoint (SUR): Blood pressure
Study 37527906 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 37528149 — Predictive Biomarker (PRD): ZNF248 mRNA
Genes: ZNF248
Study 37528149 — Predictive Biomarker (PRD): PRKRA mRNA
Genes: PRKRA; PACT; RAX; HSD-14; HSD14
Study 37528149 — Predictive Biomarker (PRD): PYHIN1 mRNA
Genes: PYHIN1; IFIX
Study 37528149 — Predictive Biomarker (PRD): SLC7A8 mRNA
Genes: SLC7A8; LAT2
Study 37528149 — Predictive Biomarker (PRD): STK19 mRNA
Genes: STK19; G11; RP1
Study 37528149 — Predictive Biomarker (PRD): ZDHHC3 mRNA
Genes: ZDHHC3; HSD49
Study 37528410 — Surrogate Endpoint (SUR): Blood pressure
Study 37528526 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37528797 — Predictive Biomarker (PRD): TXNDC5 mRNA
Genes: TXNDC5; TLP46; UNQ364/PRO700
Study 37528797 — Predictive Biomarker (PRD): CTSL mRNA
Genes: CTSL; CTSL1
Study 37528797 — Predictive Biomarker (PRD): NPC2 mRNA
Genes: NPC2; HE1
Study 37529158 — Predictive Biomarker (PRD): Hormone receptor
Study 37530627 — Predictive Biomarker (PRD): BET1 mRNA
Genes: BET1
Study 37531083 — Predictive Biomarker (PRD): CDK7 mRNA
Genes: CDK7; CAK; CAK1; CDKN7; MO15; STK1
Study 37531130 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37531657 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37532066 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study 37532416 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37532929 — Safety Biomarker (SAF): Netrin-1
Genes: NTN1; NTN1L
Study 37532979 — Surrogate Endpoint (SUR): Blood pressure
Study 37532985 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 37532985 — Safety Biomarker (SAF): Platelet to lymphocyte
Study 37533033 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study 37533033 — Surrogate Endpoint (SUR): Bone mineral density
Study 37533228 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 37533228 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 37534514 — Predictive Biomarker (PRD): Chromosome 17p
Study 37534543 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4